Johnson and Johnson pays $700m to 42 US states to settle Baby Powder asbestos claims Post date 26 June 2024 ← Colchicine in patients with acute ischaemic stroke or transient ischaemic attack → History shows that doctors’ professional identity shapes healthcare discourse—and we must not ignore it